Infectious Disease Rapid Diagnostic Testing Market Trends – Increasing Government Investments in Development of Rapid Diagnostic Testing Kits

According to Emergen Research, the global infectious disease rapid diagnostic testing market size was USD 1,660.56 million in 2020 and is expected to reach USD 3.99 billion in 2028 and register a revenue CAGR of 12.2% during the forecast period, 2021-2028.

Emergen Research has published its latest report titled “Infectious Disease Rapid Diagnostic Testing Market, By Product (Platforms, Assays), By Technology (Isothermal Nucleic Acid Amplification Technology, Enzyme Immunoassay, Real-Time PCR, Lateral Flow Immunoassay, Others), By Disease Type (Bacterial Infection, Viral Infection, Other Infections), By End-use (Hospitals & Clinics, Diagnostic Centers, Others), and By Region Forecast to 2028”

According to Emergen Research, the global infectious disease rapid diagnostic testing market size was USD 1,660.56 million in 2020 and is expected to reach USD 3.99 billion in 2028 and register a revenue CAGR of 12.2% during the forecast period, 2021-2028.

Market Dynamics:

Steady revenue growth of the global infectious disease rapid diagnostic testing market is majorly driven by factors such as rising prevalence of infectious diseases, increasing burden of target diseases, growing susceptibility of the geriatric population to infectious diseases, and rapid adoption of molecular diagnostic techniques in healthcare facilities. Rapid diagnostic testing is a highly advanced diagnostic method used to detect various infectious diseases. These tests help identify the target analyte and offer accurate results faster than most other diagnostic methods.

Market revenue growth is further driven by factors including rising trend of home health care, increasing use of point-of-care (POC) diagnostic solutions, growing demand for rapid diagnostic testing solutions amid the ongoing COVID-19 pandemic, and increasing government initiatives to raise awareness of life-threatening infectious diseases, including the EVD, MERS-CoV, and the novel coronavirus and its emerging variants. Hence, increasing caseload of COVID-19 across the globe and rising public and private investments in research & development activities for more advanced infectious disease diagnostics are expected to further boost the global market revenue growth.

Click Here to Access Free sample PDF Copy of the Report@ https://www.emergenresearch.com/request-sample/269

COVID-19 Impact Analysis:

  • Social distancing and restrictions severely disrupted businesses and operations
  • Lockdowns caused disruptions in transportation and logistics
  • Impacted manufacturing activities and mining operations globally
  • Took a toll on economy of various countries
  • Caused sudden and drastic downturn in economic activity
  • Disrupted agriculture, fisheries, dairy, and other sectors
  • Caused loss of employment and financial crisis
  • Supply impacts were further compounded owing to reduced disposable income
  • Emergence of variants continue to cause concerns and impact normal routines

Viral Infection Segment Accounted for Largest Revenue Share in 2020:

Based on disease type, the global infectious disease rapid diagnostic testing market is segmented into Bacterial Infection, Viral Infection, and Other Infections. The viral infection segment was the most dominant in terms of largest revenue share in the global market in 2020. Increasing cases of the influenza virus and hospital-acquired infections (HAIs), rapid spread of the novel coronavirus and its emerging variants across the globe, increasing caseload of COVID-19, and growing availability of rapid diagnostic tests for COVID-19 amid the pandemic are major factors boosting revenue growth of this segment.

Real-Time PCR Segment to Account for Fastest Revenue CAGR:

Based on technology, the global infectious disease rapid diagnostic testing market is segmented into Isothermal Nucleic Acid Amplification Technology, Enzyme Immunoassay, Real-Time PCR, Lateral Flow Immunoassay, and Others. The real-time PCR (polymerase chain reaction) segment is projected to register the fastest revenue growth rate in the global market over the forecast period. Growing applications of the real-time PCR technology in molecular diagnostics, owing to advantages such as robust sensitivity and specificity, low contamination risk, and higher speed and efficacy than many other diagnostic techniques, are expected to drive revenue growth of this segment.

Asia Pacific Market Accounted for Largest Revenue Share in 2020:

Among regional markets, the Asia Pacific infectious disease rapid diagnostic testing market accounted for the largest revenue share in the global market in 2020. Rapid spread of infectious diseases including the novel coronavirus infection, rising adoption of rapid diagnostic testing products & solutions for infectious diseases, increasing R&D activities for advanced infectious disease diagnostics, and rapid advancement of the region’s healthcare infrastructure – especially in developing countries including India and China – are among the primary factors driving the Asia Pacific market revenue growth.

Looking for Discount [Click on the link] @ https://www.emergenresearch.com/request-discount/269

Major Companies in the Global Infectious Disease Rapid Diagnostic Testing Market Include:

  • Abbott Laboratories
  • Danaher Corporation
  • BGI Group
  • DiaSorin S.p.A.
  • F. Hoffmann-La Roche Ltd.
  • Luminex Corporation
  • BioMérieux S.A.
  • Hologic, Inc.
  • Thermo Fisher Scientific
  • Becton, Dickinson, and Company

For the purpose of this report, Emergen Research has segmented the global infectious disease rapid diagnostic testing market based on product, technology, disease type, end-use, and region:

Product Outlook (Revenue, USD Billion; 2018-2028)

  • Platforms
  • Assays

Technology Outlook (Revenue, USD Billion; 2018-2028)

  • Isothermal Nucleic Acid Amplification Technology (INAAT)
  • Enzyme Immunoassay (EIA)
  • Real-Time PCR (q-PCR)
  • Lateral Flow Immunoassay (LFIA)
  • Others

Disease Type Outlook (Revenue, USD Billion; 2018-2028)

  • Bacterial Infection
  • CT/NG
  • HAIs
  • Tuberculosis
  • Others
  • Viral Infection
  • Hepatitis
  • Influenza Virus
  • HPV
  • HIV-AIDS
  • Others
  • Other Infections

End-use Outlook (Revenue, USD Billion; 2018-2028)

  • Hospitals & Clinics
  • Diagnostic Centers
  • Others

Have a look at Report Description and Table of Contents of Market Report@ https://www.emergenresearch.com/industry-report/infectious-disease-rapid-diagnostic-testing-market

Region Outlook (Revenue, USD Billion; 2018-2028)

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • BENELUX
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Saudi Arabia
    • U.A.E.
    • South Africa
    • Turkey
    • Rest of Middle East & Africa

Explore Related Reports by Emergen Research:

The global metaverse in finance market size was significantly robust in 2020 and is expected to register rapidly inclining revenue CAGR over the forecast period. Rapid adoption of metaverse initiatives by brokerage companies and banks to improve the business offerings, emergence of cryptocurrency as a large-scale alternative financial system, and growing focus of fintech and smaller financial companies on developing their own digital financial ecosystems are key factors expected to drive market revenue growth over the forecast period.

The global metaverse in healthcare market size was significantly robust in 2020 and is expected to register a rapid revenue CAGR over the forecast period. Some key factors driving steady market revenue growth include integration of Augmented Reality (AR), Virtual Reality (VR), and Artificial Intelligence (AI) in the healthcare sector to improve efficiency of medical equipment, enable provision of hands-on training to personnel, and diagnose and treat certain conditions.

The global metaverse in automotive market size was significantly robust in 2020 and is expected to register a rapid revenue CAGR over the forecast period. Growing focus on leveraging metaverse technology in car to create human machine interface, emerging opportunities for contextual advertising for automotive dealers, rising trend of online car buying, and increasing efforts undertaken by major automotive companies to develop their own metaverse platforms are some key factors expected to fuel market revenue growth over the forecast period.

The global metaverse in gaming market size was significantly robust in 2020 and is expected to register a rapidly inclining CAGR during the forecast period. Rapidly rising popularity of play-to-earn games, increasing efforts to create immersive gaming experiences, and growing investment to develop different versions of metaverse are some key factors expected to drive market revenue growth over the forecast period.

The global digital water market size reached USD 7.96 Billion in 2020 and is expected to register a revenue CAGR of 12.1% during the forecast period. Increasing need for better water services is resulting in growing demand for digital water services, which is a major factor expected to drive market revenue growth over the forecast period.

The global Computer-Generated Imagery (CGI) market size reached USD 3.18 Billion in 2020 and is expected to register a revenue CAGR of 19.9% during the forecast period. Increasing demand for more cost-effective animation tools and increasing need to improve brand credibility are some of the key factors expected to continue to drive global computer-generated imagery market revenue growth during the forecast period.

The global emerging memory technologies market size reached USD 4.17 Billion in 2020 and is expected to register a revenue CAGR of 30.7% during the forecast period. Increasing demand for high-end and more advanced devices and increasing need for time saving in data transferring are some of the key factors expected to continue to drive global emerging memory technologies market revenue growth during the forecast period.

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Visit for More Insights: https://www.emergenresearch.com/insights

Explore Our Custom Intelligence services | Growth Consulting Services

Read Full Press Release@ https://www.emergenresearch.com/press-release/global-infectious-disease-rapid-diagnostic-testing-market